0303.KL

Premium GrowerAI neutral

Alpha IVF Group Berhad · Healthcare · Malaysia · $331M cap · $143K/day traded

MYR 0.285 +1.8% · close 6 Nov · scored 10 Nov

Premium Grower: Strong business with the market behind it, priced at a premium.

86
Score
Get score and insider alerts
Quality
81
Value
39
Momentum
66

As of 10 Nov 2026, the MoatMap Score for Alpha IVF Group Berhad (0303.KL) is 86/100, ranked against 25,000+ stocks in 38 markets (Quality 81, Value 39, Momentum 66, each scored against its sector).

Does the score work? Each tenth of the ranking, tracked monthly. See the record →

P/E (TTM)
28.5x
peers 22.8x
ROE
28.1%
peers 9.2%
D/E
0.2x
peers 0.3x
Dividend %
5.0%
trailing yield
AI REVIEW

Alpha IVF operates fertility clinics in Malaysia and the region, with high returns on capital, strong margins and demand supported by later parenthood and medical tourism. The quality metrics are strong, but there is no recent news on new clinic openings, patient volumes or pricing, and the valuation is not obviously cheap. Growth depends on replicating its clinical outcomes in new locations.

ABOUT ALPHA IVF GROUP BERHAD

Read

Alpha IVF Group Berhad (0303.KL) is a leading provider of fertility treatment services, operating state-of-the-art assisted reproductive technology (ART) centers. The company offers a comprehensive suite of services, including in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), to patients in Malaysia and regionally. Alpha IVF's strong reputation for advanced medical techniques and high success rates positions it as a prominent specialist in the growing reproductive healthcare market.

FINANCIAL SUMMARY (MYR)

Year20222023202420252026CAGRTTM2027E2028EFwd CAGR
Revenue91.1M137.5M167.6M176.8M198.6M21.5%199.5M244.1M295.9M22.1%
EPS (MYR)0.000.010.010.010.0139.0%0.010.010.0224.3%
Shares4.9B4.9B4.9B4.9B4.8B-0.4%4.8B———
Debt30.3M23.2M16.1M23.5M33.7M2.7%33.4M———
Equity40.5M51.6M187.4M198.0M189.7M47.2%————
Op CF34.3M60.6M58.6M55.3M66.5M18.0%66.1M———
Inv CF-1.4M-93.3K-69.1M29.6M-4.6M—————
Fin CF-10.9M-37.9M73.5M-46.9M-55.4M—————
PRICE (1Y) · MYR+16.8%
0.240.260.270.280.2928 Sep19 Oct6 Nov
SMA 50SMA 200

Price checkIn an uptrendExperimental

Above its 200-day average and 11% below its 52-week high.

SwingsCalm

Calmer than 77% of stocks we rank over the past year (volatility 28% a year).

How this is worked out

The MoatMap Score weighs the business, its price and its trend. The price check reads only the chart: the price side of the Momentum score, in words.

The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: how much the price moved day to day over the past year, scaled to a yearly figure (annualised volatility) and ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
MYR 0.285
RSI (14)
60.0
52-Week Range-11.2% from high
Low MYR 0.2294High MYR 0.3211

SCORE BREAKDOWN

Quality
81
ROIC
33.4%96.7
ROE
28.1%94.0
GP/Assets
47.2%84.8
Op. Margin
35.8%94.8
FCF/Assets
15.3%93.7
Piotroski
549.5
Int. Cover
47.1x78.7
D/E Ratio
0.18x52.1
Current Ratio
2.75x52.3
Value
39
P/E (TTM)
28.5x39.7
EV/EBITDA
17.0x39.0
P/FCF
34.7x34.7
P/B
7.9x13.1
P/S
6.9x30.7
Div Yield
5.0%90.2
Momentum
66
52W High %
89%81.3
RS 6M
20%78.3
SMA 50/200
1.01x64.3
EPS Rev 4W
0.0%51.2
EPS Rev 12W
+0.1%59.1
EPS Improve
—65.8
Q Growth
-1%38.2

FUNDAMENTALS

Market Cap
$331M
P/E (Forward)
16.8x
Gross Margin
59.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 0303.KL are excluded.

TickerCompanyMkt CapScore
0303.KLAlpha IVF Group Berhad(you)$331M86
0222.KLOptimax Holdings Berhad$66M86
0101.KLTMC Life Sciences Berhad$173M66
0363.KLPMCK Berhad$52M86
0329.KLMetro Healthcare Berhad$53M84
5878.KLKPJ Healthcare Berhad$2.6B66
5225.KLIHH Healthcare Berhad$17.1B61
7148.KLDuopharma Biotech Berhad$257M89
5555.KLSunway Healthcare Holdings Berhad$5.9B33
7153.KLKossan Rubber Industries Bhd$734M96

Peer medians: ROE 9.2% · P/E 22.8x · Gross margin 34.5%

Company Deep Dive

A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.

Request Deep Dive(50 Feathers)

Alpha IVF Group Berhad (0303.KL): Stock Score Summary

Alpha IVF Group Berhad (0303.KL) has a MoatMap Score of 86/100 based on Quality (81/100), Value (39/100), and Momentum (66/100) factor scores. Alpha IVF operates fertility clinics in Malaysia and the region, with high returns on capital, strong margins and demand supported by later parenthood and medical tourism. The quality metrics are strong, but there is no recent news on new clinic openings, patient volumes or pricing, and the valuation is not obviously cheap. Growth depends on replicating its clinical outcomes in new locations.

Alpha IVF Group Berhad (0303.KL) is a leading provider of fertility treatment services, operating state-of-the-art assisted reproductive technology (ART) centers. The company offers a comprehensive suite of services, including in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), to patients in Malaysia and regionally. Alpha IVF's strong reputation for advanced medical techniques and high success rates positions it as a prominent specialist in the growing reproductive healthcare market.

Director dealings

From 10 Nov 2025 to 10 Nov 2026, MoatMap's records hold no sales and 20 purchases of Alpha IVF Group Berhad (0303.KL) shares by its directors. The largest: DATO DR LEE SOON SOO bought 2,991,000 shares at MYR 0.275 on 21 Oct 2026 (about MYR 823K).

  • 6 Nov 2026: DATO DR LEE SOON SOO bought 1,077,500 shares at MYR 0.279 (about MYR 301K)
  • 6 Nov 2026: DATO' DR LEE SOON SOO bought 1,077,500 shares
  • 4 Nov 2026: DATO DR LEE SOON SOO bought 100,000 shares at MYR 0.28 (about MYR 28K)
  • 4 Nov 2026: DATO' DR LEE SOON SOO bought 100,000 shares
  • 2 Nov 2026: DATO DR LEE SOON SOO bought 518,400 shares at MYR 0.277 (about MYR 144K)
0303.KL insider filings, last 180 days

Key Financial Metrics

PriceMYR 0.285
Market Cap$331M
P/E (TTM)28.50
P/E (Forward)16.76
Price/Book7.92
Return on Equity28.1%
Return on Invested Capital33.4%
Debt/Equity0.18x
Gross Margin59.9%
Operating Margin35.8%
Revenue Growth1.5%
Dividend Yield5.0%
Free Cash Flow$10M

Alpha IVF Group Berhad operates in the Medical Care Facilities industry, part of the Healthcare sector (Malaysia).

Frequently Asked Questions

What is Alpha IVF Group Berhad’s (0303.KL) MoatMap Score?
The MoatMap Score for Alpha IVF Group Berhad (0303.KL) is 86/100. It is a composite of Quality (81), Value (39), and Momentum (66), each scored against its sector. The composite is then ranked across MoatMap’s universe of 25,000+ stocks.
Does Alpha IVF Group Berhad have an economic moat?
Alpha IVF Group Berhad (0303.KL) has a Quality factor score of 81/100. Quality blends several measures of profitability and financial strength, led by gross profit to assets, return on invested capital and free cash flow to assets. A high score describes the financial record a durable advantage tends to leave; it does not prove a moat.
What sector is Alpha IVF Group Berhad in?
Alpha IVF Group Berhad (0303.KL) operates in the Healthcare sector, specifically the Medical Care Facilities industry (Malaysia).